The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127232311 12723231 1 I 2015 20151214 20160908 20160908 PER US-ZYDUS-009792 ZYDUS PHARM 62.00 YR F Y 0.00000 20160908 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127232311 12723231 1 PS MELOXICAM. MELOXICAM 1 Oral N UNKNOWN 77921 7.5 MG TABLET
127232311 12723231 2 C DEXTROMETHORPHAN HYDROBROMIDE/GUAIFENESIN 2 0
127232311 12723231 3 C DULOXETINE. DULOXETINE 1 U 0 30 MG
127232311 12723231 4 C FLUTICASONE FLUTICASONEFLUTICASONE PROPIONATE 1 Nasal U 0 50 UG NASAL SPRAY
127232311 12723231 5 C HYDROCODONE/PARACETAMOL 2 ONE 5/500 TABLET DAILY AS NEEDED U 0 5 MG TABLET
127232311 12723231 6 C NIFEDIPINE. NIFEDIPINE 1 U 0 10 MG TABLET
127232311 12723231 7 C SUMATRIPTAN. SUMATRIPTAN 1 U 0 100 MG
127232311 12723231 8 C LIDOCAINE. LIDOCAINE 1 U 0 TRANSDERMAL PATCH
127232311 12723231 9 C LORATADINE. LORATADINE 1 U 0 10 MG
127232311 12723231 10 C ZOLEDRONIC ACID ZOLEDRONIC ACID 1 U 0 5 MG INJECTION
127232311 12723231 11 C TOPIRAMATE. TOPIRAMATE 1 U 0 25 MG
127232311 12723231 12 C MINERALS NOS/VITAMINS NOS 2 U 0
127232311 12723231 13 C ALUMINIUM HYDROXIDE/MAGNESIUM HYDROXIDE 2 U 0 500 MG
127232311 12723231 14 C ACETYLSALICYLIC ACID ASPIRIN 1 U 0 81 MG
127232311 12723231 15 C CALCIUM CARBONATE/CALCIUM LACTOGLUCONATE 2 U 0 600 MG
127232311 12723231 16 C COLECALCIFEROL CHOLECALCIFEROL 1 U 0 3000 MG
127232311 12723231 17 C CYANOCOBALAMIN. CYANOCOBALAMIN 1 U 0 1000 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127232311 12723231 1 Osteoarthritis
127232311 12723231 2 Upper-airway cough syndrome
127232311 12723231 3 Product used for unknown indication
127232311 12723231 4 Sinus disorder
127232311 12723231 5 Arthritis
127232311 12723231 6 Raynaud's phenomenon
127232311 12723231 7 Migraine
127232311 12723231 8 Pain
127232311 12723231 9 Sinus disorder
127232311 12723231 10 Product used for unknown indication
127232311 12723231 11 Migraine prophylaxis
127232311 12723231 12 Product used for unknown indication
127232311 12723231 13 Product used for unknown indication
127232311 12723231 14 Product used for unknown indication
127232311 12723231 15 Product used for unknown indication
127232311 12723231 16 Product used for unknown indication
127232311 12723231 17 Product used for unknown indication

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
127232311 12723231 Drug ineffective Drug ineffective

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127232311 12723231 1 20150826 201511 0